Abdul Mannan: Paradox of Bleeding and Clotting in Uremic Coagulopathy
Abdul Mannan, Consultant Haematologist, Director Haemophilia Centre and Haematology Lab Lead at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Your dialysis patient is bleeding from their gut.
But their clotting tests look normal.
Sound familiar?
This is uremic coagulopathy, and most people still don’t fully understand what’s going wrong at the platelet level.
Here’s what’s actually happening:
- Excess urea generates cyanate, which carbamylates the αIIbβ3 integrin on platelets.
The fibrinogen-binding site gets structurally altered. Platelet aggregation fails at the final step.
- GPIb receptors on platelets get proteolysed, reducing von Willebrand factor adhesion.
The platelet never properly sticks to the damaged vessel wall in the first place.
- Nitric oxide and prostacyclin levels are both elevated in uraemia. Both independently inhibit platelet activation. It’s a double hit.
- Anaemia makes it worse. Below a haematocrit of 25%, red blood cells can’t physically push platelets to the vessel wall (margination).
No margination, no effective primary haemostasis.
Now here’s the part that keeps me up at night.
The same uraemic toxins that cause bleeding also drive a prothrombotic state.
- Indoxyl sulfate triggers eryptosis, exposing phosphatidylserine on red blood cell membranes.
- These surfaces act as a scaffold for coagulation factor assembly and thrombin generation.
The result?
These patients bleed from their gut, clot off their fistula and stroke.
Both. At the same time.
This is why managing bleeding in a dialysis patient isn’t just about giving desmopressin and hoping for the best.
The pathophysiology is layered, and the treatment has to match it.”

More posts from Abdul Mannan on Hemostasis Today.
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership
-
May 31, 2026, 14:31Mirjam Teboe: The Golden Rule Behind Reliable Lupus Anticoagulant Testing
-
May 31, 2026, 14:20Improving Access to Care for People Living with Haemophilia and Haemoglobinopathies – NNHF